192 related articles for article (PubMed ID: 9652759)
1. Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.
Marsh KL; Varley JM
Br J Cancer; 1998 May; 77(9):1439-47. PubMed ID: 9652759
[TBL] [Abstract][Full Text] [Related]
2. Allelic loss of chromosomal arm 8p in breast cancer progression.
Anbazhagan R; Fujii H; Gabrielson E
Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.
Kittiniyom K; Gorse KM; Dalbegue F; Lichy JH; Taubenberger JK; Newsham IF
Breast Cancer Res; 2001; 3(3):192-8. PubMed ID: 11305954
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast.
Ando Y; Iwase H; Ichihara S; Toyoshima S; Nakamura T; Yamashita H; Toyama T; Omoto Y; Karamatsu S; Mitsuyama S; Fujii Y; Kobayashi S
Cancer Lett; 2000 Aug; 156(2):207-14. PubMed ID: 10880771
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in ductal carcinoma in situ of the breast.
Stratton MR; Collins N; Lakhani SR; Sloane JP
J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715
[TBL] [Abstract][Full Text] [Related]
7. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.
Zikan M; Bohm J; Pavlista D; Cibula D
Clin Transl Oncol; 2011 Sep; 13(9):652-5. PubMed ID: 21865136
[TBL] [Abstract][Full Text] [Related]
9. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
[TBL] [Abstract][Full Text] [Related]
10. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
Koreth J; Bethwaite PB; McGee JO
J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer.
Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA
Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452
[TBL] [Abstract][Full Text] [Related]
12. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.
Munn KE; Walker RA; Varley JM
Oncogene; 1995 Apr; 10(8):1653-7. PubMed ID: 7731721
[TBL] [Abstract][Full Text] [Related]
13. Genetic pathways in the evolution of breast ductal carcinoma in situ.
Farabegoli F; Champeme MH; Bieche I; Santini D; Ceccarelli C; Derenzini M; Lidereau R
J Pathol; 2002 Mar; 196(3):280-6. PubMed ID: 11857490
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
Chappell SA; Walsh T; Walker RA; Shaw JA
Br J Cancer; 1997; 75(9):1324-9. PubMed ID: 9155053
[TBL] [Abstract][Full Text] [Related]
15. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.
Amari M; Moriya T; Ishida T; Harada Y; Ohnuki K; Takeda M; Sasano H; Horii A; Ohuchi N
Jpn J Clin Oncol; 2003 Nov; 33(11):556-62. PubMed ID: 14711979
[TBL] [Abstract][Full Text] [Related]
17. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
Visscher DW; Wallis TL; Crissman JD
Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
[TBL] [Abstract][Full Text] [Related]
19. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
20. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]